Endothelial Cell-Activating Antibodies in COVID-19.

Hui ShiYu ZuoSherwin NavazAlyssa HarbaughClaire K HoyAlex A GandhiGautam SuleSrilakshmi YalavarthiKelsey GockmanJacqueline A MadisonJintao WangMelanie ZuoYue ShiMichael D MaileChristian LoodYogendra Kanthi

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2022)

These data are the first to indicate that some COVID-19 patients have potentially diverse antibodies that drive endotheliopathy, providing important context regarding thromboinflammatory effects of autoantibodies in severe COVID-19.

Keyphrases

sars cov
coronavirus disease
endothelial cells
respiratory syndrome coronavirus
systemic lupus erythematosus
signaling pathway
electronic health record
early onset
big data
machine learning
data analysis